Task: Answer the multiple-choice question.
Question: Which drug exhibits a -14.109% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: COc1ccc(-c2nnc(Nc3ccc(CC(N)=O)cc3)c3ccccc23)cc1
b: CC(=O)N1Cc2cc(N)ccc2Oc2ccccc21
c: CCOC(=O)/C(C#N)=C/NC(=O)NC(C)(C)C
d: O=C(Cn1cnc2sc(-c3ccccc3)cc2c1=O)NCc1ccco1
e: Cc1[nH]n(-c2ccc([N+](=O)[O-])cc2)c(=O)c1C=NCCN1CCN(C(=O)c2cccc(F)c2)CC1
Answer: a. COc1ccc(-c2nnc(Nc3ccc(CC(N)=O)cc3)c3ccccc23)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(-c2nnc(Nc3ccc(CC(N)=O)cc3)c3ccccc23)cc1
COc1ccc(-c2nnc(Nc3ccc(CC(N)=O)cc3)c3ccccc23)cc1
2-[4-[[4-(4-methoxyphenyl)phthalazin-1-yl]amino]phenyl]acetamide